Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vincent Medical HoldingsHKSE:01612 +1.43%49 FCF Margin % is 12.70% as of Dec. 2025, which is 252% above its 10-year median of 3.61. GuruFocus rates HKSE:01612 with a GF Score™ of 49/100 and a GF Value™ of HK$0.58 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Vincent Medical Holdings ranks better than 62.62% on this metric.
The historical rank and industry rank for Vincent Medical Holdings's FCF Margin % or its related term are showing as below:
HKSE:01612'
s FCF Margin % Range Over the Past 10 Years
Min: -8.65 Med: 3.61 Max: 12.28
Current: 5.08
During the past 13 years, the highest FCF Margin % of Vincent Medical Holdings was 12.28%. The lowest was -8.65%. And the median was 3.61%.
HKSE:01612's FCF Margin % is ranked better than 62.62% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs HKSE:01612: 5.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01612 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Vincent Medical Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vincent Medical Holdings FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vincent Medical Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Vincent Medical Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vincent Medical Holdings (HKSE:01612) has a FCF Margin % of 12.70% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vincent Medical Holdings and its competitors. This is 252% above median its historical median of 3.61. According to the industry distribution chart, Vincent Medical Holdings ranks #305 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 37.4%.
Is Vincent Medical Holdings' FCF Margin % too high?
Vincent Medical Holdings' current FCF Margin % of 12.70% is 252% above median its 10-year median of 3.61. Based on the distribution chart, Vincent Medical Holdings ranks #305 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Vincent Medical Holdings has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vincent Medical Holdings' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vincent Medical Holdings ranks #305 out of 816 companies for FCF Margin %. This puts Vincent Medical Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vincent Medical Holdings and its competitors. Vincent Medical Holdings's current FCF Margin % is 12.70%, which is 252% above median its own 10-year median of 3.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vincent Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vincent Medical Holdings (HKSE:01612) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.58, compared to a current price of HK$0.71 — trading 22.4% above its estimated fair value. The current FCF Margin % is 12.70%, which is 252% above median its 10-year median of 3.61. Vincent Medical Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vincent Medical Holdings (HKSE:01612), the current FCF Margin % is 12.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vincent Medical Holdings (HKSE:01612) Overvalued in 2026?
Based on GuruFocus' analysis, Vincent Medical Holdings stock appears to be overvalued.
The current stock price of HK$0.71 is trading 22.4% above its estimated GF Value™ of HK$0.58.
GuruFocus considers Vincent Medical Holdings to be Modestly Overvalued.
Key valuation signals for HKSE:01612:
FCF Margin %: 12.70% (252% above median its 10-year median of 3.61)
GF Value™: HK$0.58 vs. price of HK$0.71 (22.4% above fair value)
No single metric tells the full story. See the HKSE:01612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices focusing on imaging disposable products on an OEM basis to one of the world's diagnostic imaging solutions providers. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer's requirements. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under the Inspired Medical, and Hand of Hope brands. The geographical segments of the company includes the United States, Spain, the PRC, Japan, Costa Rica, the Netherlands, Germany, and Others. It derives its maximum revenue from Spain.
49GF Score
Get the complete analysis for HKSE:01612
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01612 has been successfully added to your 
